Challenges and New Strategies in the Management of Gliomas

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Methodology, Drug and Device Discovery".

Deadline for manuscript submissions: 25 July 2025 | Viewed by 1040

Special Issue Editors


E-Mail Website
Guest Editor
Laboratory of Neuronal Networks, Department of Mental and Physical Health and Preventive Medicine, University of Campania ''Luigi Vanvitelli", 80138 Naples, Italy
Interests: central nervous system plasticity; glioblastoma microenvironment; tumor–glia inter-action; blood–brain barrier; peripheral nerve injury
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Drug and Health Sciences, University of Catania, 95100 Catania, Italy
Interests: neuroanatomy; neuroscience; neuropeptides; neural stem cells; identification of carcinogenic bi-omarkers; study of molecular mechanisms involved in cancers progression
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor

Special Issue Information

Dear Colleagues,

High-grade gliomas represent a unique challenge for research. The tumors grow as masqued behind a plethora of neurological signs and their systemic effects. The intra-tumor and inter-tumor heterogeneity and the alliance with brain elements reveal them at an advanced stage. Surgery is possible depending on the neuro-anatomical location. Recurrent neoplastic cores often arise in the peritumoral area beyond the primary resection. Resistance to chemo and radiotherapy makes them very difficult to treat.

Despite advances in personalized medicine, immunotherapy, and the high-precision ion beam approach, the patient prognosis remains unfavorable, requiring urgent studies to understand brain tumor biology, polarization of the microenvironment, and systemic mechanisms.

The present Special Issue aims at collecting ideas, hypotheses, and proof to identify specific biomarkers within the mechanisms occurring in the brain tumor microenvironment, offering potential avenues for central nervous system re-education, personalized medicine, early diagnosis, and non-invasive anti-tumor approaches. Journal articles, reviews, and communications are welcomed.

Dr. Assunta Virtuoso
Prof. Dr. Agata Grazia D'Amico
Dr. Celeste Caruso Bavisotto
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • brain tumors
  • human
  • mammals
  • astrocytes
  • microglia
  • oligodendroglia
  • neuroanatomy
  • neuropeptides
  • imaging

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

11 pages, 444 KiB  
Review
Brain Stem Glioma Recurrence: Exploring the Therapeutic Frontiers
by Francesco Pasqualetti, Giuseppe Lombardi, Giovanni Gadducci, Noemi Giannini, Nicola Montemurro, Alberto Feletti, Marco Zeppieri, Teresa Somma, Maria Caffo, Chiara Bertolotti and Tamara Ius
J. Pers. Med. 2024, 14(9), 899; https://doi.org/10.3390/jpm14090899 - 25 Aug 2024
Viewed by 757
Abstract
Gliomas of the brainstem represent a small percentage of central nervous system gliomas in adults. Due to the proximity of the tumor to critical structures, radical surgery is highly challenging and limited to selected cases. In addition, postoperative treatments, which become exclusive to [...] Read more.
Gliomas of the brainstem represent a small percentage of central nervous system gliomas in adults. Due to the proximity of the tumor to critical structures, radical surgery is highly challenging and limited to selected cases. In addition, postoperative treatments, which become exclusive to non-operable patients, do not guarantee satisfactory disease control, making the progression of the disease inevitable. Currently, there is a lack of therapeutic options to control tumor growth after the diagnosis of recurrence. The rarity of these tumors, their distinct behavioral characteristics, and the limited availability of tumor tissue necessary for the development of prognostic and predictive biomarkers contribute to the absence of a standardized approach for treating recurrent brainstem gliomas. A salvage radiotherapy (RT) retreatment could represent a promising approach for recurrent brainstem gliomas. However, to date, it has been mainly evaluated in pediatric cases, with few experiences available to assess the most appropriate RT dose, safety, and clinical responses in adult patients. This comprehensive review aims to identify instances of adult patients with recurrent brainstem gliomas subjected to a secondary course of RT, with a specific focus on the analysis of treatment-related toxicity and outcomes. Through this investigation, we endeavor to contribute valuable insights into the viability and efficacy of salvage RT retreatment in managing recurrent brainstem gliomas in the adult population. Full article
(This article belongs to the Special Issue Challenges and New Strategies in the Management of Gliomas)
Show Figures

Figure 1

Back to TopTop